EN
HI
Summary
As of 31 Aug, 2026, Jagsonpal Pharmaceuticals stock price is ₹240.84. During the trading session, the stock has moved between an intraday low of ₹235.86 and an intraday high of ₹247.90. Over the last 52 weeks, Jagsonpal Pharmaceuticals has traded between ₹155.00 and ₹264.50.
The stock has recorded a trading volume of 2,35,599 shares, with a market capitalization of ₹65835470. Its Average Traded Price (ATP) is ₹242.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹240.84.
Jagsonpal Pharmaceuticals has an upper circuit limit of ₹286.87 and a lower circuit limit of ₹191.25. The total value traded stands at ₹5.71 CR, and the delivery percentage for the day is 50.32%.
The stock is currently traded with a market lot size of 1. Jagsonpal Pharmaceuticals also offers a dividend yield of 0%.
Jagsonpal Pharmaceuticals share price chart
Jagsonpal Pharmaceuticals Share Key Metrics
Volume
2.36 L
Market Cap
1585.58 CR
LTQ@LTP
25@240.84
ATP
242.24
Var Margin
20.02 %
Circuit Range
191.25-286.87
Delivery %
50.32 %
Value
5.71 CR
ASM/GSM
No
Market Lot
1
Jagsonpal Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Jagsonpal Pharmaceuticals Resistance and Support
Pivot 239.36
Resistance
First Resistance
242.55
Second Resistance
246.05
Third Resistance
249.24
Support
First Support
235.86
Second Support
232.67
Third Support
229.17
Jagsonpal Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 239.9 | 240.84 | 0.75% | 247.9 | 235.86 |
| Fri Aug 28 2026 | 237.75 | 239.05 | 0.87% | 242.86 | 236.16 |
| Thu Aug 27 2026 | 242 | 236.99 | -2.15% | 242.66 | 235.1 |
Jagsonpal Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-27 | Audited Results & Final Dividend |
| 2026-03-12 | Buy Back of Shares |
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Stock Split |
| 2024-08-07 | Quarterly Results |
Jagsonpal Pharmaceuticals News
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Jagsonpal Pharmaceuticals will convene its 47th Annual General Meeting (AGM) on September 24, 2026, at 11:00 AM (IST) through video conferencing. The meeting will address ordinary and special business, including consideration of a final dividend. The record date for voting and dividend entitlement is September 16, 2026.
Aug 28 2026 12:05:33
Jagsonpal Pharmaceuticals Management
| Name | Position |
|---|---|
| Pratham Rawal | Company Secretary & Compliance Officer |
| Harsha Raghavan | Chairperson |
Jagsonpal Pharmaceuticals Similar Stocks
Suraksha Diagnostic Ltd.
338.55
-1.65 (0.49%)
NGL Fine-Chem Ltd.
2649.50
-163.90 (5.83%)
Shalby Ltd.
155.27
0.62 (0.40%)
Fermenta Biotech Ltd.
500.10
-9.80 (1.92%)
Amrutanjan Health Care Ltd.
509.35
-4.90 (0.95%)
KMC Speciality Hospitals (India) Ltd.
135.52
-2.53 (1.83%)
Q-Line Biotech Ltd.
595.55
46.60 (8.49%)
Gujarat Kidney And Super Speciality Ltd.
158.14
-2.50 (1.56%)
Sigachi Industries Ltd.
32.62
-0.54 (1.63%)
GPT Healthcare Ltd.
153.01
1.29 (0.85%)
Jagsonpal Pharmaceuticals FAQs
The Buying Price of Jagsonpal Pharmaceuticals share is 240.84 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jagsonpal Pharmaceuticals is 1585.58 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 264.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jagsonpal Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JAGSNPHARM
Or Download Choice FinX App
Invest in JAGSNPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade